Juan Capurro Boltendahl
Juan has over 25 years Investment Banking experience. He specializes in M&A transactions, Private Equity investments and Venture Capital projects. Prior to founding the M&A boutique Boltendahl International in 1996, he worked with Deutsche Bank in Frankfurt, with the ING Group in Montevideo and with Banco Medefin in Buenos Aires. To date Juan is based in Germany, leading Boltendahl’s European operations. He is an advisor of several international companies in its acquisition and divestment strategies. His sector expertise focuses on: pharmaceuticals and healthcare, biotech, medical devices, medTech, retail and consumer goods, and TMT. He has worked in more than 200 M&A cases, advising a broad range of companies and funds.
His corporate finance expertise started back in the late 80’s while holding and representing major shareholders in Asbach, Germany’s biggest brandy company. Juan played an important role in the sale process to the Guinness/United Distillers Group.
His most recent deals include Series A CHF 9.5m and Series B CHF 30m private placements in Swiss MedTech Fertility company Ava AG; the sale of Spanish CRO company Villapharma Research to listed group Eurofins Scientific; the closing of the debt tranche for the Spanish private equity powerhouse Portobello Capital in its acquisition of the leading digital signage company Trison; two Series A and B investments in the Israeli company Corephotonics Ltd.; a series D investment in the American company CloverFoodLab; the divestment and DLA Agreement with Valeant / Bausch+Lomb for a Swiss pharmaceutical client; the acquisition of a logistics leader in Spain for the French company Groupe CAT; and an Asset deal with Holcim Spain for a Latin American concrete group.
Juan is member of the IESE Alumni Association of Madrid and a founding member of the IESE Junta Territorial (IESE Regional Board) in Argentina and Uruguay. Juan obtained his MBA at IESE in Barcelona and also attended Columbia University of New York. He speaks Spanish, English, German, Portuguese and French.
Erik Robert Hartmann
Pharma Partner Latam & USA
Erik is member of the Board of the following companies: Tecnofarma SA of Argentina, LaboratoriosRaffo of Chile and from investment company Perutil SA, formerly listed at the Swiss Stock Exchange. In 1984 Erik joined J.P. Morgan where he worked in the Zurich and New York offices, in both commercial banking and investment banking management positions.
Since 1990 Erik R. Hartmann works in the pharmaceutical industry, he is responsible for licensing and business development in Tecnofarma, a major Latin American pharmaceutical company.
Erik Hartmann has negotiated important corporate partnerships with multinational pharmaceutical and biotechnology companies such as Novartis, Switzerland; Purdue Pharma, USA; Biogenidec, USA; and LG Chemical, Korea. He originated and advised in a major acquisition by Novartis (Sandoz) in Argentina.
Erik was born in 1957, obtained his Master of Economics at the University of St. Gallen in Switzerland, is married and has two children. He has the Swiss and Argentine nationalities and speaks German, English and Spanish.
Guillermo Rodriguez Capurro
Guillermo is a graduate in Law and Social Sciences from the University of the Republic, Uruguay, he possesses over ten years of experience in the legal corporate field.
Between the years 2005 and 2015, Guillermo worked at several of the most prestigious law firms in Uruguay, such as Posadas and Posadas & Vecino. Furthermore, he worked as a legal counsel for BAF CAPITAL, the investment fund management company, where he performed Investment Management activities.
Guillermo is proficient in different fields of law, including: commercial law, corporate law, sports law and intellectual property, having also developed and assessed real estate businesses in the area.
Among other activities, he presently conducts legal counseling at the prestigious and popular Club Nacional de Football.
Along his legal expertise, Guillermo presents a defined commercial profile, and speaks Spanish, English and Portuguese.
Partner Latam - Legal
Director Stem Cell Practice
Wolfgang has 20+ years of management experience with international entrepreneurial and worldwide business development capabilities. In 2004 he founded Secuvita, SL a leading UCB company in Spain. He has achieved an important stature in the biotechnology space in Spain, leading a premium brand in the nascent Stem Cell Storage industry. His expertise ranges from founding, to leading through seed phase, to guiding of full commercialization to obtain profitability, to strategic guidance and positioning, and to international expansions.
Prior to that he worked as a General Manager for IDOC in Rio de Janeiro, leading the firm to become one of the first companies to achieve ISP status in Brazil, building a Web Development/E-business consulting unit, featuring www.infoinvest.com.br, the premier Brazilian Investor Relations Portal, with a significant client base in the financial services sector. Following that experience he served for 6 years as a VP of worldwide Operations at Bowne Global Solutions, a leading US based technology company (after BGS acquired IDOC).
Wolfgang obtained his International Executive MBA from IE in Madrid and graduated in Sociology and Psychology from the University of Vienna. He speaks German, English, Spanish and Portuguese.
Non-Executive Director / London
Marc is an expert in finance and strategy consulting with over 14 years of experience. From 2000 to 2003 he worked as a senior consultant in the London office of McKinsey & Company, serving financial institutions mainly in Europe. Prior to that, he spent 9 years at Deutsche Bank in Germany, France and Belgium, working as vice-president in its global markets division.
He is currently a member of the well-known Candesic consultancy, which is also associated with Boltendahl. He specialises in strategy, market analysis and market due diligence. In addition to his finance and consulting activities, Marc lectures in several European MBA programmes, including Edhec Theseus, Sciences Po and ESCP-EAP.
Marc obtained his MBA from the University of Chicago GSB. He also graduated from the Edhec business school and attended the Young Managers Program at INSEAD. He speaks French, English, German, and conversational Spanish and Russian.